High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
about
Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) studyAntipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.Psychotropic drug use and mortality in old people with dementia: investigating sex differences.A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease.Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study.Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease.Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.Drug use in persons with and without Alzheimer's disease aged 90 years or more.Antipsychotic drug use and associations with neuropsychiatric symptoms in persons with impaired cognition: a cross-sectional study.Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up.Time trends in antipsychotic drug use in patients with dementia: a nationwide study.Neuropsychiatric symptoms and psychotropic drug use in patients with dementia in general practices.Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany.Quality of care for people with dementia and professional caregivers' perspectives regarding palliative care in Japanese community care settings.Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.Evolution of the Antidepressant Prescribing in Alzheimer's Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer's Disease (BNA).Behavioral and psychological symptoms of dementia in older residents in long-term care facilities in Japan: a cross-sectional studyThe use of psychotropic drugs for behavioral and psychological symptoms of dementia among residents in long-term care facilities in Japan
P2860
Q28384359-4AB4CA29-D4D2-4B89-9F71-188A111716CEQ33604532-51FE204B-38B7-4A96-8361-0108B112F2C4Q33729950-319F26DD-BCAA-427C-92D5-7DC1EF88B6A3Q36206447-7B047B1E-10D3-4E8F-8275-A4DB10AD8DD9Q36302602-C6A23967-CA99-4BF5-9571-C465DCC4C605Q37746403-C1B3D226-CD6D-4EDB-8229-607D476EABD6Q38648405-3AABA0DA-6CB8-4F20-BA1C-4612EAC158E1Q38684601-2F302E81-EF6C-4AED-ADDF-78429D2DB98EQ38720657-137E19C2-D24F-4BED-B732-7CBDFFEFB2AEQ38987617-93A844DE-D579-47F2-87F5-8B31EEFFCAF2Q39038647-D71C9C39-A0E7-4AFE-8DA4-B04F8922CF03Q39115650-C54BF000-252F-4A8A-A582-37E6CE0C603DQ39136336-285CCE3D-5382-423A-A36A-BFCD65D74A93Q39163869-57F6A009-E81A-4F15-885F-7E1428BC36A4Q39192134-A7C860BA-84C9-4483-8A8B-FE5FE2978CE9Q39244637-13CF5A7C-A61D-4CC2-A544-1A2860BD0E6AQ39409144-4FAB6A4D-F6EB-47B5-A1F9-8C4A4796F0EEQ39684580-FA9B06D7-4B96-401B-9F71-F0E979C7DD3CQ39961795-CAFB03D2-2FB8-4F55-94E0-5C9327E05714Q40457871-B6DA018E-456C-471E-A362-A803FF29E050Q47604461-9C52FD1B-ACD3-4945-9E0C-A3C5EE4ACB7EQ47680282-9CCDDE30-E7D6-4E0E-9145-7BF6D52F2C96Q47875379-696D7DCB-3D48-4588-A7BB-829C3E6FC63FQ48294578-51F0B26E-A32E-441A-9E82-C9A8882E87D0Q50637315-08DE6413-0F21-44E8-953E-74566FB18002Q58103871-11D386E5-9F07-4594-AEDB-30D7BF576998Q58254740-FB99F1A0-C004-47D6-A41D-A115630C8146
P2860
High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
High prevalence of psychotropi ...... in Finnish nationwide cohort.
@en
type
label
High prevalence of psychotropi ...... in Finnish nationwide cohort.
@en
prefLabel
High prevalence of psychotropi ...... in Finnish nationwide cohort.
@en
P2093
P50
P1476
High prevalence of psychotropi ...... in Finnish nationwide cohort.
@en
P2093
Antti Tanskanen
Heidi Taipale
Marjaana Koponen
P304
P356
10.1016/J.EURONEURO.2014.10.004
P407
P577
2014-11-01T00:00:00Z